The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.
Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
The Food and Drug Administration on Friday approved ... which help people shave pounds. The FDA first approved Zepbound to treat obesity in November 2023. Its active ingredient, tirzepatide ...
The U.S. Food and Drug Administration (FDA) is demanding increased, in-your-face food transparency when it comes to nutrition ...
In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...
Red Dye No. 3, also known as erythrosine, is a synthetic food dye that gives foods and drinks a bright red color. It is also ...
Jan 17 (Reuters) - The U.S. Food and Drug Administration has approved ... Enhertu, was first approved by the FDA in 2019 for a type of breast cancer and later expanded for use in multiple conditions.
After the recent ban on Red Dye 3, food manufacturers are turning to FDA-approved dyes like Red Dye 40. But is Red 40 safe?